-negative bacilli has led to polymyxins B and E being used once again, as a “salvage” therapy in the patients with CRE (carbapenems-resistant Enterobacteriaceae) infections for which we do not have the better treatment options (Li et al. 2006; Nation and Li 2009; Lim et al. 2010). Orally and topically administered colistin sulphate and parenteral colistin methanesulphonate sodium are designed for the treatment of life-threatening human infections caused by Gram-negative rods. Colistin has been approved
ELŻBIETA M. STEFANIUK,
Polish Journal of Microbiology , ISSUE 4, 417–427
. The prognosis is generally poor, and death occurs in approximately 80% of cases as a result of transtentorial herniation and brainstem compression (Back, Nagaraja, Kapur, & Eslick, 2015).
Treatment options include intravenous (IV) thrombolysis within 4.5 hours of stroke onset, endovascular clot retrieval (ECR) within 24 hours of stroke onset and surgical decompressive surgery.
Significant studies have shown that early decompressive craniectomy (DC) in patients aged <60 years within 48 hours of
Kwan Yee (Queenie) Leung,
Australasian Journal of Neuroscience , ISSUE 1, 5–12
most prominent and recent (up to 2014 year) publications on the treatment and mechanisms of epilepsy in selected neurocutaneous disorders. We aimed to emphasize evidence-based medicine recommendations as well as basic experimental studies dealing with molecular mechanisms of epileptogenesis. Discussion and conclusions. Recent advances in disease-modifying treatment options such as mTOR inhibitors in patients with tuberous sclerosis complex open up new perspectives for neurologists. Traditional
Journal of Epileptology , ISSUE 2, 99–108
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and fluctuating muscle weakness (Hickey, 2009). The physiology of this disease is well understood and there are numerous medically focused articles that outline historical data, randomized controlled trials of treatment options and unusual case studies. The nursing literature about MG is limited and dated. The aim of this study was to examine and understand the lived experiences of
Australasian Journal of Neuroscience , ISSUE 1, 40–46
Background. Monotherapy is the choice regimen to treat newly diagnosed epilepsies. However, if it fails, several strategies may be followed. Aim. To discuss the treatment options when an initial monotherapy regimen fails. Methods. We reviewed the relevant literature on the topic by using PubMed. Review and Discussion. Approximately 64% of people with epilepsy (PWE) de novo are free of seizures with the first appropriate antiepileptic drug (AED) in monotherapy. The type (first versus second
Journal of Epileptology , ISSUE 2, 109–112
needs be noted that currently other class D carbapenemases have also been detected, i.e. OXA-23, OXA-24/40, OXA-51, OXA-58, OXA-134a, OXA-143, OXA-211, OXA-213, OXA-214, OXA-229 and OXA-235 mainly in Acinetobacter bacteria and in particular A. baumannii, while they have not been detected in the species K. pneumoniae .
Review of antibiotic treatment options of infections due to carbapenem-resistant strains
Gram-negative bacteria producing KPC, MBL or OXA-48 type carbapenemases are
Sylwia Joanna Chmielewska,
Postępy Mikrobiologii - Advancements of Microbiology , ISSUE 3, 271–289
Postępy Mikrobiologii - Advancements of Microbiology , ISSUE 3, 291–299